Your browser doesn't support javascript.
loading
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome.
Admiraal, Rick; Jol-van der Zijde, Cornelia M; Furtado Silva, Juliana M; Knibbe, Catherijne A J; Lankester, Arjan C; Boelens, Jaap Jan; Hale, Goeff; Etuk, Aniekan; Wilson, Melanie; Adams, Stuart; Veys, Paul; van Kesteren, Charlotte; Bredius, Robbert G M.
Afiliação
  • Admiraal R; Division of Stem Cell Transplantation, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.
  • Jol-van der Zijde CM; Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, University of Leiden, Leiden, The Netherlands.
  • Furtado Silva JM; Pediatric Blood and Marrow Transplantation Program, Prinses Maxima Center, Utrecht, The Netherlands.
  • Knibbe CAJ; Division of Stem Cell Transplantation, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.
  • Lankester AC; Bone Marrow Transplantation Department, Great Ormond Street Hospital, London, UK.
  • Boelens JJ; Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, University of Leiden, Leiden, The Netherlands.
  • Hale G; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands.
  • Etuk A; Division of Stem Cell Transplantation, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.
  • Wilson M; Pediatric Blood and Marrow Transplantation Program, Prinses Maxima Center, Utrecht, The Netherlands.
  • Adams S; Stem Cell Transplant and Cellular Therapies, Memorial Sloane Kettering Cancer Center, New York, NY, USA.
  • Veys P; GH Developments, Oxford, UK.
  • van Kesteren C; Department of Haematology, Camelia Botnar Laboratories, Great Ormond Street Hospital, London, UK.
  • Bredius RGM; Department of Haematology, Camelia Botnar Laboratories, Great Ormond Street Hospital, London, UK.
Clin Pharmacokinet ; 58(12): 1609-1620, 2019 12.
Article em En | MEDLINE | ID: mdl-31131436
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Alemtuzumab / Antineoplásicos Imunológicos / Modelos Biológicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Clin Pharmacokinet Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Alemtuzumab / Antineoplásicos Imunológicos / Modelos Biológicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Clin Pharmacokinet Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Holanda